Four cholinesterase inhibitors have been approved by the FDA for treating Alzheimer's. Three of these are often prescribed: Aricept (donepezil), Razadyne (galantamine), and Exelon (rivastigmine). The fourth, Cognex (tacrine) is rarely prescribed nowadays, due to its liver toxicity.
23 mg Aricept: Drug Dosage Was Approved Despite WarningFour months before a best-selling Alzheimer's drug was set to lose its patent protection, its makers received approval for a higher dosage that extended their exclusive right to sell the drug. But the
http://www.nytimes.com/2012/03/23/business/drug-do...
Cholinesterase inhibitor efficacy -- brief overviewMedication for Alzheimer's disease
Last updated: Tuesday, December 09, 2008
Currently, three drugs are available that can improve memory and delay disease progression in Alzheimer's disease. The d
http://www.health24.com/medical/Condition_centres/...
Cholinesterase inhibitor use in nursing homesApproximately One-Third of Nursing Home Residents With Dementia Use Cholinesterase Inhibitors: Presented at AAGP
By Emma Hitt, PhD
HONOLULU -- March 8, 2009 -- Cholinesterase inhibitors are used
http://www.docguide.com/news/content.nsf/news/8525...
Cholinesterase Inhibitors -- Assessing Their EffectsManagement of Alzheimer's Disease: Assessing the Effects of Cholinesterase Inhibitors
(From: The Canadian Journal of Diagnosis, Vol. 20, No. 6, p. 49-52.)
Editorial Consultant
Bernard Groulx, M
http://www.acc.gc.ca/print.cfm...
Cholinesterase inhibitors -- Cochrane database reviewSUMMARY
Cholinesterase inhibitors (ChEIs), donepezil, galantamine and rivastigmine are efficacious for mild to moderate Alzheimer's disease
Alzheimer's disease is the commonest cause of dementia
http://www.cochrane.org/reviews/en/ab005593.html
Cholinesterase inhibitors delay nursing-home placementCholinesterase inhibitors may delay nursing-home placement in Alzheimer's
There is considerable debate on the value of the cholinesterase inhibitors (donepezil, rivastigmine, galantamine, etc.) in
http://www.ukmicentral.nhs.uk/headline/database/vi...
Cholinesterase inhibitors for managing behavioral problemsAbstract: Alzheimer's disease is characterized by progressive cognitive and functional decline and the emergence of behavioral disturbances. Behavioral symptoms, in particular, cause great distress
http://www.pubmedcentral.nih.gov/articlerender.fcg...
Criteria for prescribing / using cholinesterase inhibitorsUpdated Criteria for Use: Cholinesterase Inhibitors to Treat Dementia
VHA Pharmacy Benefits Management Service and the Medical Advisory Panel
The following recommendations are based on current m
http://www.pbm.va.gov/criteria/Cholinesterase%20In...
Do cholinesterase inhibitors modify disease progressionAbstract: Much evidence shows that cholinesterase inhibitor drugs such as Aricept, Exelon and reminyl are clinically effective treatments for people with Alzheimer's disease, and probably also help
http://alzheimers.org.uk/site/scripts/documents_in...
Generic Drugs for Alzheimer'sAlzheimer's Association statement: Switching to generic galantamine
In Alzheimer’s disease, as with any medical condition, physicians consider several factors before deciding which medications wil
http://www.alz.org/national/documents/statement_ge...
Long-term use of cholinesterase inhibitors -- 2000 reviewCholinesterase inhibitors stabilize Alzheimer's disease.
Giacobini E.
University Hospitals of Geneva, Department of Geriatrics, University of Geneva, Medical School, CH-1226 Thonex, Geneva
http://www.ncbi.nlm.nih.gov/pubmed/11193171
Long-term use of cholinesterase inhibitors -- 2005 studyCognitive performance in patients with Alzheimer's disease receiving cholinesterase inhibitors for up to 5 years.
Bullock R, Dengiz A.
The cholinesterase inhibitors (ChE-Is)--rivastigmine, donep
http://www.ncbi.nlm.nih.gov/pubmed/15963209
Long-term use of cholinesterase inhibitors -- 2007 reviewIs long-term treatment of Alzheimer's disease with cholinesterase inhibitor therapy justified?
Seltzer B.
The cholinesterase inhibitors (ChEIs) donepezil, rivastigmine and galantamine are th
http://www.ncbi.nlm.nih.gov/pubmed/17953456
Long-term use of cholinesterase inhibitors -- 2008 paperThe effect of cholinesterase inhibitors on decline in multiple functional domains in Alzheimer's disease: a two-year observational study in the Sunnybrook dementia cohort
Pearl Behl, Krista L. Lanc
http://journals.cambridge.org/action/displayAbstra...
Results from the first long-term study of Alzheimer's drugsExtended treatment with Alzheimer's disease drugs can significantly slow the rate at which the disorder advances, and combination therapy with two different classes of drugs is even better at helping
http://esciencenews.com/articles/2008/09/22/study....
Rivastigmine for Alzheimer's disease -- Cochrane ReviewSummary: Rivastigmine is beneficial for people with Alzheimer's disease.
Alzheimer's disease (AD) is the commonest cause of dementia affecting older people, and is associated with loss of cholinerg
http://www.cochrane.org/reviews/en/ab001191.html
Trio of Drugs May Improve Alzheimer'sTrio of Drugs May Improve Alzheimer's
Modest Gains in Mental Skills Seen With Aricept, Razadyne, and Exelon
By Miranda Hitti
WebMD Health News
Reviewed by Louise Chang, MD
Jan. 25, 2006 -- For
http://www.webmd.com/alzheimers/news/20060125/trio...
Watchdog Groups Asks FDA to Withdraw Donepezil 23 MgShortly after patent protection on donepezil (Aricept) expired late in 2009, the manufacturer introduced a new version containing a higher dose, with advertisements claiming it was effective for treat
http://journals.lww.com/neurotodayonline/Fulltext/...
